Albrecht Von Menges

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Recommended - Individuals: prosecution and nullity

Established in 1958, Uexküll & Stolberg fields a deep bench of 18 patent attorneys across twin offices in Munich and Hamburg. Its diverse clientele includes Danish biotechnology company Chr Hansen, $255 billion petroleum titan ExxonMobil and pharmaceutical originators Amgen and Bristol Myers-Squibb, which have variously engaged the firm for patent filings, international portfolio management and representation in EPO opposition proceedings. Leading on a significant chunk of this work is biotechnology head and immunology PhD Albrecht von Menges, who has stacked up 20 years of EPO advocacy experience. His team includes the likes of “flexible, amiable and technically capable” André Guder, a molecular biology PhD who previously worked at a patent law firm in Chicago. Chemistry know-how is supplied by Bernd Christian Janssen – who also served time at a Chicago law firm – and Heinz-Peter Muth, who holds a doctorate in nucleic acid chemistry and undertook post-doctoral research at the Salk Institue for Biological Studies in San Diego.

Get unlimited access to all IAM content